Back to the main directory
EarningsReview / Equity
- Truecaller (Buy, TP: SEK46.00) - Facing easy comparables in Q1 by DnB Markets
- Gentian Diagnostics (Buy, TP: NOK57.00) - Record sales in Q1 by DnB Markets
- Cargotec (Buy, TP: EUR88.00) - Attractively valued quality by DnB Markets
- Valaris (Buy, TP: USD100.00) - Closer to earnings ramp-up by DnB Markets
- March 24 stronger than expected in the US, FY video game content estimate slightly raised by BNP Paribas Exane
- Great 'classic Arkema' bolt-on in Adhesives by BNP Paribas Exane
- AENA: 1Q’24 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- ARCELOR MITTAL: 1Q’24 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- Q1'24: small beat on margins, no raise by BNP Paribas Exane
- Lottomatica - HEALTHY UNDERLYING TRENDS, NET OF SPORTS PAY-OUT by Equita Sim
- Slight Q1 beat on revenue, Q2 guided in line; new CFO appointed by BNP Paribas Exane
- First Look: Q1 Revs Beat, EBITDA margin miss by BNP Paribas Exane
- Small beat with no change to guidance (first take and read across) by BNP Paribas Exane
- 1Q24 beat, FY24 guidance adjusted on FX, operational growth raised by BNP Paribas Exane
- SenSen Networks - Time to scale by Edison Investment Research
- Q1 beat on margins; ’24 guidance raised by BNP Paribas Exane
- Airtac (1590 TT) by HSBC
- Strong 1Q24 Beat; Guide Right-sized for Modestly Lower Sales; Motional Stake Reduced; ~$1.5B Share Repo by BNP Paribas Exane
- Vestas Wind Systems - Keep calm and enjoy the tailwind into 2025 by Danske Bank Equity Research
- GlobalFoundries Inc (GFS US) by HSBC
- Nien Made (8464 TT) by HSBC
- Q1’24 call feedback: less eventful than the share price would suggest by BNP Paribas Exane
- Conference Call Takeaways by BNP Paribas Exane
- Q1 2024 Conference call feedback by BNP Paribas Exane
- Solid KPIs across business lines, outlook positive by BNP Paribas Exane